Welcome to our dedicated page for MSP Recovery SEC filings (Ticker: MSPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MSP Recovery's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MSP Recovery's regulatory disclosures and financial reporting.
MSP Recovery, Inc. notified the SEC it cannot timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026. The company cites severe liquidity constraints, reliance on loan funding, and that it is "actively evaluating and pursuing financing and reorganization alternatives, including preparation for a potential restructuring process." The filing also states the Chief Financial Officer resigned effective February 17, 2026, which "created incremental operational constraints" for completing the quarter-end close. The company says it is implementing interim measures and will file the Form 10-Q as soon as practicable; timing depends on its ability to obtain sufficient financing. The notification is signed by CEO John H. Ruiz on May 18, 2026.
Nasdaq Stock Market LLC has notified removal of MSP Recovery, Inc. securities from Nasdaq listing and/or registration, citing applicable Exchange rules and 17 CFR 240.12d2-2 provisions. The filing names the affected classes as Class A Common Stock and two series of redeemable warrants, including warrants exercisable at $50,312.50 per share and at $0.4375 per share. The form carries an expiry reference of March 31, 2018 and is signed by a Nasdaq hearings advisor.
MSP Recovery, Inc. files a prospectus supplement to register up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, and up to 236,019 shares of Class A common stock issuable upon exercise of warrants, for resale by named selling securityholders. The supplement incorporates a Form 8-K dated May 6, 2026 and reflects a 1-for-7 reverse stock split effective September 1, 2025.
The Form 8-K discloses two one-time short-term financings: a $0.1 million discretionary advance from Hazel Partners Holdings, LLC under the existing working capital facility and a separate $0.1 million one-time advance from VRM MSP Recovery Partners, LLC, each described as standalone accommodations with no commitment for further funding.
MSP Recovery, Inc. amends its prospectus to register 285,715 shares of Class A Common Stock for resale by YA II PN, Ltd. (Yorkville) under the existing Standby Equity Purchase Agreement. The registration supports issuances and resales tied to the Yorkville SEPA and related Convertible Notes, which include conversion mechanics, a 9.99% Ownership Limitation and an Exchange Cap that was lifted effective January 8, 2025. The company notes multiple reductions to the SEPA Floor Price culminating at $0.50, the transfer of listing from Nasdaq to the OTCQB, and a reported closing price of $0.0418 for Common Stock on May 5, 2026.
MSP Recovery, Inc. files a prospectus supplement to register 32,220 shares of Class A Common Stock for resale by selling securityholders, including up to 15,239 shares issuable upon exercise of the CPIA Warrant. The supplement attaches a Form 8-K that discloses two one-time short-term advances: a $0.1 million advance from Hazel Partners to increase discretionary availability under an existing working capital facility, and a $0.1 million advance from VRM MSP Recovery Partners, LLC repayable upon certain financings. The filing notes a 1-for-7 reverse stock split effective September 1, 2025 and market prices quoted as of May 5, 2026. The CPIA Warrant exercise would produce nominal proceeds at its $0.4375 per-share strike.
MSP Recovery, Inc. filed a prospectus supplement registering the resale of up to 56,896 shares of Class A Common Stock by selling securityholders, including shares issuable upon exercise of warrants and shares issued as consideration. The supplement attaches a Form 8-K that discloses two one-time advances of $0.1 million each from Hazel Partners Holdings LLC and VRM MSP Recovery Partners, LLC to support operations and accounts payable. The supplement notes a 1-for-7 reverse stock split effective September 1, 2025, and provides closing market prices as of May 5, 2026. The exercise price for certain warrants is $0.0175 per share, so any proceeds from those exercises would be nominal.
MSP Recovery, Inc. entered two small, one-time funding arrangements that highlight its constrained liquidity. Through a Hazel Partners Holdings LLC letter agreement, the company received a $0.1 million discretionary advance under its existing working capital credit facility, increasing prior Operational Collection Floor advances of about $6.0 million. The facility remains fully discretionary, provides no committed liquidity, and offers no additional availability beyond this single advance.
The company also signed an Advance Letter with VRM MSP Recovery Partners, LLC, under which VRM provided a separate $0.1 million one-time advance of recovery proceeds to support accounts payable. MSP Recovery must reimburse VRM for this advance and certain prior consents upon closing any future financing, including potential debtor-in-possession financing if it operates under Chapter 11 protection. Both agreements expressly state there is no obligation for further funding and caution that these advances should not be viewed as evidence of future liquidity.
MSP Recovery, Inc. files a prospectus supplement registering 285,715 shares of Class A Common Stock for resale by YA II PN, Ltd. (Yorkville) under a previously disclosed Standby Equity Purchase Agreement (the "Yorkville SEPA"). The supplement incorporates a Form 8-K describing updates to the Yorkville arrangements and short-term lender advances.
The Yorkville SEPA permits the Company to sell shares to Yorkville (up to $250 million in aggregate issuances subject to an Ownership Limitation and other caps), and Yorkville holds convertible notes and advance rights described in the supplement. The prospectus notes the Company will not receive proceeds from Yorkville's resale activity; proceeds to the Company may arise only from shares it elects to sell to Yorkville under the SEPA.
MSP Recovery, Inc. registers 56,896 shares of Class A Common Stock for resale under its S-1 prospectus supplement. The supplement breaks the offering into warrants-related issuances and shares issued for services, and notes a 1-for-7 reverse split effective September 1, 2025.
The filing also attaches a Current Report describing two one-time $0.1 million advances: a Hazel discretionary Operational Collection Floor advance and a VRM advance to support accounts payable; both advances are described as standalone accommodations.
MSP Recovery, Inc. filed Prospectus Supplement No. 65 to its S-1 registering up to 909,982 shares of Class A common stock and related resale rights in connection with private and dividend-issued warrants and other legacy instruments. The supplement incorporates an April 16, 2026 Current Report on Form 8-K that discloses two one-time advances of $0.1 million each from Hazel Partners Holdings, LLC and VRM MSP Recovery Partners, LLC to support operating needs and accounts payable. The prospectus notes adjusted warrant economics after the Business Combination, including Public Warrant exercise price of $0.4375 and New Warrant exercise price of $50,312.50, and reports an April 17, 2026 closing common share price of $0.0382. The filing emphasizes that the New Warrants are unlikely to be cash-exercised at current market prices and that the advances are one-time accommodations, with no committed further funding under the working capital facility or from VRM.